A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.
about
Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales.Measuring symptoms as a critical component of drug development and evaluation in hematological diseasesPretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).Relationship between deficits in overall quality of life and non-small-cell lung cancer survivalUsing the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study.Metrics to assess quality of life after management of early-stage lung cancer.Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship.Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions.Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).The psychometric properties of cancer multisymptom assessment instruments: a clinical review.Meaning-centered dream work with hospice patients: A pilot study.The Impact of Frailty on Patient-Centered Outcomes Following Aortic Valve Replacement.Cancer-Related Fatigue in Adolescents and Young Adults After Cancer Treatment: Persistent and Poorly Managed.Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials.Stress level, health behaviors, and quality of life in employees joining a wellness center.Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice.Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Global Quality of Life Among WHI Women Aged 80 Years and Older.Is usage of a wellness center associated with improved quality of life?How do people with chronic kidney disease value cancer-related quality of life?Value assessment in oncology drugs: funding of drugs for metastatic breast cancer in Canada.
P2860
Q30879995-0F048A6F-03EA-47F1-B1D9-544881A1C159Q33705743-EA043D38-7ED2-4752-B44D-476A51055C23Q34196497-06FA0E2E-4D97-4A04-9045-3A8F28767B60Q34866427-CC82F868-54F0-4007-9A94-49DCBCE6977AQ36002272-5F651D4B-7B0B-48C4-82A7-06E317689CDBQ36058286-46568235-73C3-4B0E-9D02-E36E7D14289CQ36080860-D2D9FDDF-D493-459D-8EC5-586518C4882DQ36311501-6FA0D404-4DBC-4282-B8A6-8BAFD4653BC2Q36439549-58DB4875-56FD-4D00-82E9-B51B0729E06AQ36486055-ADA8DC11-380F-49CA-87CF-77C6FFDF234BQ36851034-40E68417-DA55-4E92-A9D8-8B195EEA1816Q37325066-F73CBFD7-AE20-4763-AEC3-26193CA92E85Q37684605-6D488373-275C-4E30-BAFE-78D36D3BC7F0Q37827010-9018DF06-ABFC-47B0-927D-F476D1855876Q38430860-D0FE2E21-A46D-4490-9B15-31D91CBED653Q39113285-65F84D69-2252-427A-8BC3-D86B86281C0BQ39304953-A68884D1-5AC1-4D8E-A2E3-C04D4842B654Q42380678-0096F06A-18F1-4975-9713-DA9B6774A837Q45165699-61B185EC-C0A7-4FD8-949F-62E7E649A4D0Q45487167-DF34C950-88CE-4F27-86F6-FA05EB15CE0FQ47110733-E422B514-1F60-4DB6-9611-B7CEF2988BB6Q47657613-08ABFCF5-C21D-439C-B2B6-0B6DD618E741Q47831331-E29D81D5-D708-4E8D-A3A8-2E12A677EE12Q48301323-CD3A6B09-1D69-4823-854D-6AB44912C0DDQ48563886-AAA4DD0F-61ED-4E2D-B0F5-0BF12F606BB4Q55365709-82E403B5-793C-4A39-9232-666398AA19CA
P2860
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A pooled analysis of quality o ...... p lung cancer clinical trials.
@ast
A pooled analysis of quality o ...... p lung cancer clinical trials.
@en
A pooled analysis of quality o ...... p lung cancer clinical trials.
@nl
type
label
A pooled analysis of quality o ...... p lung cancer clinical trials.
@ast
A pooled analysis of quality o ...... p lung cancer clinical trials.
@en
A pooled analysis of quality o ...... p lung cancer clinical trials.
@nl
prefLabel
A pooled analysis of quality o ...... p lung cancer clinical trials.
@ast
A pooled analysis of quality o ...... p lung cancer clinical trials.
@en
A pooled analysis of quality o ...... p lung cancer clinical trials.
@nl
P2093
P356
P1433
P1476
A pooled analysis of quality o ...... p lung cancer clinical trials.
@en
P2093
James R Jett
Jeff A Sloan
Mashele M Huschka
Paul L Schaefer
Sumithra J Mandrekar
P304
P356
10.1002/CNCR.22444
P407
P577
2007-02-01T00:00:00Z